ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,1672
0,00%
Bitcoin
69.002,97
0,69%
Brent Oil
81,965
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Adamis Pharmaceuticals Corporation (ADMP)

  7. Adamis Pharmaceuticals Corporation (ADMP) Notícias

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ADMP
DataHoraFonteTítuloCódigoCompanhia
08/09/202317:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/09/202313:00GlobeNewswire Inc.Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic FocusNASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/08/202310:15GlobeNewswire Inc.Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/08/202317:38Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/08/202317:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
04/08/202314:43GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of $8.0 Million Public OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
03/08/202317:55Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/08/202309:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
02/08/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/07/202317:58Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/07/202309:30GlobeNewswire Inc.Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid ExpertNASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/07/202307:08Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/07/202317:37Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/06/202308:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use DisorderNASDAQ:ADMPAdamis Pharmaceuticals Corporation
22/06/202308:30GlobeNewswire Inc.Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose PreventionNASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/06/202307:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/06/202316:22Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
30/05/202319:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/05/202317:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
25/05/202317:26GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of the Merger with DMK PharmaceuticalsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/05/202313:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Reverse Stock SplitNASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/05/202317:47GlobeNewswire Inc.Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
08/05/202317:05GlobeNewswire Inc.Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/05/202318:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/05/202317:32Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/04/202317:53Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/03/202317:24GlobeNewswire Inc.Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/03/202316:59Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/03/202317:01GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/03/202309:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces $3.0 Million Registered Direct OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:ADMP

Seu Histórico Recente

TSXV
EM
TSXV
FRR
TSX
GTE
Gran Tierra Energy
TSX
NVA
NuVista Energy
NYSE
ELY
Callaway Golf
AMEX
LAQ
TSX
X
TMX
TSX
SXI
Synex Renewable Energy
TSXV
ZAP.H
TSXV
SLO
NASDAQ
CERC
Cerecor
TSXV
PIE
BOV
XPML12
Xp Malls Fundo Investime...
TSX
SVB
Silver Bull Resources
BOV
RBRD11
Rb Capital Renda Ii Fund...
TSXV
SNY
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados